2014 annual financial data
Corcept Therapeutics 2014 Operating cash flow margin
Direct answer
Operating cash flow margin was -103.11%.
Operating income was -27,619,000 USD and net income was -31,383,000 USD.
Operating cash flow was -27,376,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,551,000 USD
- Operating income
- -27,619,000 USD
- Net income
- -31,383,000 USD
- Operating cash flow
- -27,376,000 USD